Bio-gate AG

BIG1 · XETRA · Healthcare / Medical Instruments & Supplies

2.60EUR+0.02 (+0.78%)

Price History

Full chart

Market Stats

Previous Close2.58

Open2.58

Day Range2.58 – 2.60

52-Week Range2.50 – 4.85

Volume0

Market Cap1.33M

P/E (TTM)0.00

Forward P/E7.70

EPS-0.60

Dividend Yield0.00%

Beta0.02

50-Day Avg3.17

200-Day Avg3.49

About

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is based in Nuremberg, Germany.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Marc Lloret-Grau
Employees51
HeadquartersNeumeyerstrasse 28-34, Nuremberg, Germany, 90411, Germany
Websitehttps://www.bio-gate.de

Leadership

Mr. Marc Lloret-GrauChairman of the Management Board, CEO & MD
Thomas KonradtDirector of Business Development & Member of Executive Board

Financials

Income Statement

Currency: EUR	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	5.13M	6.24M	5.99M	7.25M	7.05M	7.40M
Growth (%)	-	+21.49%	-3.93%	+20.97%	-2.66%	+4.92%
Cost of Revenue	2.06M	2.41M	2.41M	3.37M	2.92M	3.09M
Gross Profit	3.07M	3.83M	3.58M	3.88M	4.14M	4.31M
Gross Margin	59.91%	61.39%	59.76%	53.52%	58.63%	58.21%
Operating Expense	3.89M	4.36M	5.36M	5.47M	5.74M	5.44M
Operating Income	-815.53K	-534.85K	-1.78M	-1.59M	-1.60M	-1.13M
Operating Margin	-15.89%	-8.58%	-29.74%	-21.95%	-22.73%	-15.25%
Net Income	-804.88K	-544.12K	-1.81M	-1.62M	-1.62M	-1.16M
Net Income Margin	-15.68%	-8.73%	-30.15%	-22.38%	-22.99%	-15.74%
Interest Expense	22.02K	23.27K	23.08K	47.80K	55.81K	88.37K
Interest Expense % of Total Revenue	0.43%	0.37%	0.39%	0.66%	0.79%	1.19%

Balance Sheet

Currency: EUR	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	3.31M	5.21M	6.22M	5.26M	3.95M	4.66M
Total Liabilities	1.76M	1.44M	1.97M	1.81M	2.16M	3.06M
Total Equity	1.56M	3.67M	4.15M	3.37M	1.75M	1.53M
Cash	419.24K	1.97M	1.61M	1.33M	296.62K	704.93K

Cash Flow

Currency: EUR	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-597.00K	-634.00K	-2.15M	-977.00K	-1.22M	-1.01M
Capital Expenditure	107.00K	538.00K	445.00K	145.00K	106.00K	407.00K
Free Cash Flow	-704.00K	-1.17M	-2.60M	-1.12M	-1.32M	-1.41M
FCF to OCF	117.92%	184.86%	120.65%	114.84%	108.71%	140.42%

Key Statistics & Ratios

Market Cap1.33M

Enterprise Value32.33M

Trailing P/E0.00

Forward P/E7.70

PEG Ratio0.00

Price / Sales0.17

Price / Book3.59

EPS-0.60

Book Value0.15

Revenue (TTM)7.74M

Gross Profit (TTM)4.31M

EBITDA-893.58K

Profit Margin-15.05%

Operating Margin-6.72%

Return on Equity-71.99%

Return on Assets-16.39%

Shares Outstanding2.04M

Shares Float4.90M

Beta0.02

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jul 28, 20261:5